1 / 7

World

World. tubal ligation 32%. vasectomy 7%. IUD 22%. condom 7%. CI/PA 13%. oral contraceptives 14%. D/P/S 5%. Germany. IUD 8%. tubal ligation 1%. oral contraceptives 77%. vasectomy 2%. condom 6%. CI/PA 4%. Nieschlag & Behre Andrology 2nd ed.

Download Presentation

World

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. World tubal ligation 32% vasectomy 7% IUD 22% condom 7% CI/PA 13% oral contraceptives 14% D/P/S 5% Germany IUD 8% tubal ligation 1% oral contraceptives 77% vasectomy 2% condom 6% CI/PA 4% Nieschlag & Behre Andrology 2nd ed. Springer 2000 D/P/S 2% EN-F1620E

  2. EN-F1767

  3. Approaches to male contraception Methods in use Vasectomy Vas occlusion Condom Coitus interruptus Physical approach Ultrasound Temperature Immunological Immun. against sperm approach antigens (e.g. p34h) Pharmacological Chlorinated sugars approach Nitroimidazole derivatives Sulfasalazine Gossypol Tripterigium wilfordii Hormones Nieschlag & Behre Andrology 2nd ed. Springer 2000 EN-F1529E

  4. Approaches to hormonal male contraception Nieschlag 2002 1. Inhibition of FSH 2. Testosterone (T) alone 3. T + gestagens 4. T + estrogens 5. T + 5a-reductase inhibitors 6. T + GnRH agonists 7. T + GnRH antagonists EN-F1530b

  5. The Weimar Manifesto on Male Contraception June 29, 1997 “... The researchers agreed that clinical research had shown that a reversible male hormonal contraceptive is feasible and effective ...” “... Since any contraceptive method can only be brought to practical usage by pharmaceutical com-panies, the researchers urged the pharmaceutical industry to become actively involved in the develop-ment of novel male contraceptives...” EN-F1519E (From Nieschlag & Behre, Testosterone, 2nd ed. Springer 1998)

  6. EN-F960

More Related